The research revealed a concerning finding, stating that individuals using GLP-1 receptor agonists, such as semaglutide, for a duration of one to three years might face an elevated risk of developing various types of thyroid cancers
ICAM1 mRNA level tended to be higher in obesity group compared to non-obesity group, but it did not reach a significant difference
Provincial healthcare considerations also vary across Canada
99 Until more robust trials confirm their safety specifically in patients with reduced LVEF, GLP-1 RAs should be used cautiously in this population
It supports joint stability, bone density, and functional movement
Every patient receives medical oversight, education, and ongoing monitoring in our program